News
The FDA has accepted for review a resubmission of the BLA for bevacizumab-vikg (ONS-5010) for the treatment of wet AMD.
A new study from the Koret School of Veterinary Medicine at the Hebrew University of Jerusalem, led by Dr. Lionel Sebbag, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback